Boston Scientific warns it may miss guidance after cyberattack
Boston Scientific said management is unlikely to hit quarterly and full-year guidance targets as fallout from a cyberattack in late August affects its financial results.
Boston Scientific (BSX) said its financial results have been affected following a recent cyberattack on the medical device maker. Management said it is unlikely to meet quarterly and full-year guidance targets as the fallout from a cyberattack in late August continues to weigh on the company.